Fertility outcome of patients with testicular tumor: Before and after treatment

Asian Journal of Andrology

Volumn 16, Issue 1, 2014, Pages 107-111

  Ping, Ping ^a   Gu, Ben Hong ^b   Li, Peng ^a,c   Huang, Yi Ran ^a   Li, Zheng ^a,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Traditional Chinese Medicine (TCM) Integrated Hospital   (China)

^c Shanghai Key Laboratory for Reproductive Medicine   (China)

Author keywords

chemotherapy; fertility; radiotherapy; sperm bank; testicular cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; AZOOSPERMIA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CONCEPTION; CONGENITAL MALFORMATION; CRYOPRESERVATION; FERTILITY PRESERVATION; FOLLOW UP; HEALTH CARE FACILITY; HUMAN; INFERTILITY THERAPY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MALE FERTILITY; MULTIMODALITY CANCER THERAPY; ORCHIECTOMY; QUESTIONNAIRE; RETROSPECTIVE STUDY; SPERM; TELEPHONE INTERVIEW; TESTIS CANCER; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHINA; CRYOPRESERVATION; FERTILITY; HUMANS; INFERTILITY, MALE; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; RETROSPECTIVE STUDIES; SEMEN PRESERVATION; SPERMATOGENESIS; TESTICULAR NEOPLASMS;

EID: 84891940722     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.4103/1008-682X.122194     Document Type: Article

References (34)

1. McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, et al. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 2003; 91: 63-70.
2. Schagen SB, Boogerd W, Muller MJ, Huinink WT, Moonen L, et al. Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Oncol 2008; 47: 63-70.
3. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, et al. EUROCARE-4 Working Group. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007; 8: 784-96.
4. Shetty G, Meistrich ML. Hormonal approaches to preservation and restoration of male fertility after cancer treatment. J Natl Cancer Inst Monogr 2005; 33: 36-9.
5. Huyghe E, Matsuda T, Daudin M, Chevreau C, Bachaud JM, et al. Fertility after testicular cancer treatments: results of a large multicenter study. Cancer 2004; 100: 732-7.
6. Kim C, McGlynn KA, McCorkle R, Zheng T, Erickson RL, et al. Fertility among testicular cancer survivors: a case-control study in the U.S. J Cancer Surviv 2010; 4: 266-73.
7. Fraietta R, Spaine DM, Bertolla R P, Ortiz V, Cedenho AP. Individual and seminal characteristics of patients with testicular germ cell tumors. Fertil Steril 2010; 94: 2107-12.
8. O'Flaherty C, Hales BF, Chan P, Robaire B. Impact of chemotherapeutics and advanced testicular cancer or Hodgkin lymphoma on sperm deoxyribonucleic acid integrity. Fertil Steril 2010; 94: 1374-9.
9. Brennemann W, Stoffel-Wagner B, Helmers A, Mezger J, Jäger N, et al. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer. J Urol 1997; 158: 844-50.
10. Magelssen H, Brydøy M, Fosså SD. The effects of cancer and cancer treatments on male reproductive function. Nat Clin Pract Urol 2006; 3: 312-22.
11. De Mas P, Daudin M, Vincent MC, Bourrouillou G, Calvas P, et al. Increased aneuploidy in spermatozoa from testicular tumour patients after chemotherapy with cisplatin, etoposide and bleomycin. Hum Reprod 2001; 16: 1204-8.
12. Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am. 1998; 27: 927-43.
13. Colpi GM, Contalbi GF, Nerva F, Sagone P, Piediferro G. Testicular function following chemo-radiotherapy. Eur J Obstet Gynecol Reprod Biol 2004; 113: S2-6.
14. Beck SD, Bey AL, Bihrle R, Foster RS. Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection. J Urol 2010; 184: 2078-80.
15. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Nat Cancer Inst Monogr 2005; 34: 12-7.
16. O'Flaherty CM, 'Chan PT, hHales B F, aRobaire B. Sperm chromatin structure components are differentially repaired in cancer survivors. J Androl 2012; 33: 629-36.
17. Shalet SM, Tsatsoulis A, Whitehead E, Read G. Vulnerability of the human leydig cell to radiation damage is dependent upon age. J Endocrinol 1989; 120: 161-5.
18. Stahl O, Eberhard J, Cavallin-Stahl E, Jepson K, Friberg B, et al. Sperm DNA integrity in cancer patients: the effect of disease and treatment. Int J Androl 2009; 32: 695-703.
19. Trottmann M, Becker AJ, Stadler T, Straub J, Soljanik I, et al. Semen quality in men with malignant diseases before and after therapy and the role of cryopreservation. Eur Urol 2007; 52: 355-67.
20. Girasole CR, Cookson MS, Smith JA Jr, Ivey BS, Roth BJ, et al. Sperm banking: use and outcomes in patients treated for testicular cancer. BJU Int 2007; 99: 33-6.
21. Scammell GE, White N, Stedronska J, Hendry WF, Edmonds DK, et al. Cryopreservation of semen in men with testicular tumour or Hodgkin's disease: results of artificial insemination of their partners. Lancet 1985; 2: 31-2.
22. Ragni G, Somigliana E, Restelli L, Salvi R, Arnoldi M, et al. Sperm banking and rate of assisted reproduction treatment: insights from a 15-year cryopreservation program for male cancer patients. Cancer 2003; 97: 1624-9.
23. Spermon JR, Kiemeney LA, Meuleman EJ, Ramos L, Wetzels AM, et al. Fertility in men with testicular germ cell tumors. Fertil Steril 2003; 79: 1543-9.
24. Skinner R, Wallace WH, Levitt G. Long-term follow-up of children treated for cancer: why is it necessary, by whom, where and how? Arch Dis Child 2007; 92: 257-60.
25. Matos E, Skrbinc B, Zakotnik B. Fertility in patients treated for testicular cancer. J Cancer Surviv 2010; 4: 274-8.
26. Brydoy M, Fossa SD, Klepp O, Bremnes RM, Wist EA, et al. Paternity following treatment for testicular cancer. J Natl Cancer Inst 2005; 97: 1580-8.
27. Magelssen H, Haugen TB, von During V, Melve KK, Sandstad B, et al. Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it? Eur Urol 2005; 48: 779-85.
28. Hawkins MM. Pregnancy outcome and offspring after childhood cancer. BMJ 1994; 309: 1034.
29. Said TM, Tellez S, Evenson DP, Del Valle A P. Assessment of sperm quality, DNA integrity and cryopreservation protocols in men diagnosed with testicular and systemic malignancies. Andrologia 2009; 41: 377-82.
30. Gandini L, Sgrò P, Lombardo F, Paoli D, Culasso F, et al. Effect of chemo-or radiotherapy on sperm parameters of testicular cancer patients. Hum Reprod 2006; 21: 2882-9.
31. Spermon JR, Ramos L, Wetzels AM, Sweep CG, Braat DD, et al. Sperm integrity pre-and post-chemotherapy in men with testicular germ cell cancer. Hum Reprod 2006; 21: 1781-6.
32. Stahl O, Eberhard J, Jepson K, Spano M, Cwikiel M, et al. The impact of testicular carcinoma and its treatment on sperm DNA integrity. Cancer 2004; 100: 1137-44.
33. Bieber AM, Marcon L, Hales B F, Robaire B. Effects of chemotherapeutic agents for testicular cancer on the male rat reproductive system, spermatozoa, and fertility. J Androl 2006; 27: 189-200.
34. Smit M, van Casteren NJ, Wildhagen MF, Romijn JC, Dohle GR. Sperm DNA integrity in cancer patients before and after cytotoxic treatment. Hum Reprod 2010; 25: 1877-83.